Genomictree Inc. (228760) — Cash Flow Reinvestment Rate
Genomictree Inc. (228760) has a Cash Flow Reinvestment Rate of 3.71x as of December 2022, reinvesting ₩15.89 Billion (capex ₩1.82 Billion plus investments ₩14.07 Billion) from operating cash flow of ₩4.29 Billion. Explore Genomictree Inc. capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Genomictree Inc. Cash Flow Reinvestment Rate (2022–2022)
Historical reinvestment intensity for Genomictree Inc. across 1 annual periods. Also explore Genomictree Inc. assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Genomictree Inc. (2022–2022)
Year-by-year capital reinvestment analysis for Genomictree Inc.. For live market cap and broader valuation context, see Genomictree Inc. (228760) total market value.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 3.71x | ₩15.89 Billion | ₩4.29 Billion | ₩1.82 Billion | — |